CenterPoint Energy (CNP)
NYSEUtilitiesRegulated ElectricSnapshot 2026-09-04
$39.67-0.78%
Close 2026-09-04 · 1-day change
NYSEUtilitiesRegulated ElectricSnapshot 2026-09-04
Research Workspace
Put CNP beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Multi-Utilities is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Full-year 2026 EPS near $1.9 per share: FY26 EPS guidance $1.89-$1.91 vs $1.89 target.
View ThesisRevenue is growing steadily — about 7% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 40%, softest on free-cash-flow margins.
View QualityManagement screens strong on margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskCNP's growth relies on executing its 10-year capital investment plan and maintaining EPS guidance. Revenue growth is supported by strong Q2 performance, which beat estimates. CNP trades at 2.3× price-to-book, slightly above the 2.0× peer median, indicating it looks expensive on this basis. The primary risk is the potential for a guidance cut, with a 20% chance of missing expectations. Peer multiples imply a price about 4% below where it trades. This read is provisional; the thesis is on watch due to pressure on a primary pillar.
Trailing returns as of 2026-09-04. CNP is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 17 analysts currently covering CNP (as of Sep 2026).
Based on 7 Wall Street analysts offering 12-month price targets for CNP in the last 4 months.
Continue this research
Compare CNP with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CNP Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Multi-Utilities — fair value, gap to price, and forward P/E.
Compare the value case
Put CNP next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Execute and expand 10-year capital investment plan
Upgrade supports capital investment plan and financial stability.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $39.67
The last 12 months of price, then the range of analyst 12-month targets from today’s $39.67.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Execute and expand 10-year capital investment plan
Strong Q2 performance supports capital investment execution.
Threatens: Support electric load growth in Houston
AC issues may hinder electric load growth in Houston.
Advances: Reiterate full-year 2026 EPS guidance
Eligibility for interconnection supports growth and EPS guidance.
Threatens: Reiterate full-year 2026 EPS guidance
Earnings beat but shares slipped, indicating market concerns.
Earnings beat supports EPS growth guidance.
Revenue decline raises concerns about future growth.
Earnings beat supports EPS growth expectations.